All sites C00-96,D32-33,D42-43,D45-47,D76 669 92.5 1.7 1.9 0.5 3.3
Mouth, pharynx C00-14 9 97.7 - - - 2.3
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 4 100.0 - - - -
  Salivary glands C07-08 1 85.7 - - - 14.3
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 122 85.6 1.3 6.4 0.5 6.2
  Oesophagus C15 4 94.4 - 5.6 - -
  Stomach C16 11 98.2 - 1.8 - -
  Small intestine C17 2 100.0 - - - -
  Colon C18 41 95.6 - 2.0 - 2.5
  Rectum, rectosigmoid C19-20 19 96.8 - - - 3.2
  Anus C21 1 85.7 14.3 - - -
  Liver C22 9 95.5 - 2.3 - 2.3
  Gallbladder, bile ducts C23-24 8 65.0 - 17.5 - 17.5
  Pancreas C25 26 57.8 5.5 19.5 2.3 14.8
  Other digestive organs C26 2 62.5 - - - 37.5
Respiratory organs C30-39 36 86.5 6.2 2.2 0.6 4.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 34 87.7 6.4 1.2 0.6 4.1
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 40 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 7 94.3 - - - 5.7
Breast C50 206 99.2 0.4 0.1 0.1 0.2
Female genital organs C51-58 71 95.2 0.8 1.1 0.6 2.3
  Cervix uteri C53 6 96.6 - 3.4 - -
  Corpus uteri C54 38 100.0 - - - -
  Uterus, other C55,C58 0 - - - - 100.0
  Ovary C56 16 83.8 3.8 2.5 2.5 7.5
  Other female genital C51-52,C57 11 96.3 - 1.9 - 1.9
Urinary organs C64-68 36 92.7 - 2.8 1.7 2.8
  Kidney C64 21 89.4 - 4.8 1.9 3.8
  Bladder and urinary tract2 C65-68 15 97.3 - - 1.3 1.3
Eye C69 0 50.0 - 50.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 23 87.8 - 4.3 0.9 7.0
Thyroid gland C73 16 97.5 2.5 - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 13 69.2 7.7 7.7 3.1 12.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 61 80.4 7.8 0.3 1.3 10.1
  Hodgkin lymphoma C81 2 90.0 - - - 10.0
  Non-Hodgkin lymphoma C82-86,C96,D76 25 99.2 - - - 0.8
  Malignant immunoproliferative diseases C88 0 50.0 50.0 - - -
  Myeloma and other plasma cell tumors C90 10 62.5 10.4 2.1 - 25.0
  Leukaemia C91-95 15 67.1 21.1 - 2.6 9.2
  Myelodysplastic syndromes D46 4 55.6 11.1 - - 33.3
  Myeloproliferaitive neoplasms D45,D47 5 76.0 - - 8.0 16.0
Not included above
  Carcinoma in situ of the breast D05 15 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 44 100.0 - - - -
  Borderline tumour of the ovary D39 9 97.8 - 2.2 - -
  Basal cell carcinoma of the skin 201 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.